Novo Nordisk CEO grilled over company's pricing for the diabetes drug Ozempic and the weight-loss drug Wegovy.

U.S. Senator Bernie Sanders said on Tuesday he had commitments from the nation's top pharmacy benefit managers that they ...

As the hearing opened on Tuesday, Sanders said that Novo had already made billions of dollars from the medicines. “All we are ...

U.S. Senator Bernie Sanders announced that pharmacy benefit managers have agreed to expand coverage for Novo Nordisk's ...

Bernie Sanders, I-Vt., the chair of the Senate Health Committee ... drug prices on Capitol Hill Sanders asked Jørgensen why ...

U.S. Senator Bernie Sanders announced he obtained commitments from top pharmacy benefit managers to expand coverage for Novo Nordisk's diabetes and weight-loss drugs if their list prices are reduced.

The chief executive of the company behind Ozempic and Wegovy blamed insurers and middlemen for the high costs of weight-loss ...

If the policy to expand Medicare’s $2,000 annual cap managed to weave through Congress, it is unclear how many people would benefit.